Currently out of the existing stock ratings of Stephanie Davis, 115 are a BUY (64.25%), 54 are a HOLD (30.17%), 10 are a SELL (5.59%).

Stephanie Davis

Work Performance Price Targets & Ratings Chart

Analyst Stephanie Davis, currently employed at BARCLAYS, carries an average stock price target met ratio of 71.7% that have a potential upside of 20.76% achieved within 158 days. Previously, Stephanie Davis worked at LEERINK.

Stephanie Davis’s has documented 364 price targets and ratings displayed on 24 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on GDRX, Goodrx Holdings at 11-Nov-2024.

Wall Street Analyst Stephanie Davis

Analyst best performing recommendations are on LVGO (LIVONGO HEALTH).
The best stock recommendation documented was for PHR (PHREESIA) at 3/31/2022. The price target of $29 was fulfilled within 1 day with a profit of $2.64 (10.02%) receiving and performance score of 100.15.

Average potential price target upside

of $30.63 (15.6%) on VEEV (VEEVA SYSTEMS).
of $18.38 (18.91%) on TDOC (TELADOC).
of $11.3 (17.48%) on CERN (CERNER CORP).

ACCD Accolade CERN Cerner Corp CPSI Computer Programs and Systems GDRX Goodrx Holdings HMSY HMS Holdings Corp HQY HealthEquity INOV Inovalon Holdings MDRX Allscripts Healthcare Solutions PHR Phreesia RCM R1 RCM TALK Talkspace TRHC Tabula Rasa HealthCare VCRA Vocera Communications VEEV Veeva Systems NUAN Nuance Communications NXGN Nextgen Healthcare PINC Premier TDOC Teladoc DOCS Doximity HCAT Health Catalyst ATHN athenahealth CHNG Change Healthcare EVH Evolent Health LVGO Livongo Health

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Stan Berenshteyn (WELLS FARGO)